Alkem Laboratories Ltd.
BSE: 539523 | Sector: Health care |
NSE: ALKEM | ISIN Code: INE540L01014 |
BSE 00:00 | 03 Feb | 3052.60 |
-22.00 (-0.72%) |
OPEN
3080.05 |
HIGH
3087.65 |
LOW
3035.95 |
NSE 00:00 | 03 Feb | 3051.25 |
-24.80 (-0.81%) |
OPEN
3085.00 |
HIGH
3085.00 |
LOW
3032.20 |
OPEN | 3080.05 |
PREVIOUS CLOSE | 3074.60 |
VOLUME | 1086 |
52-Week high | 3720.00 |
52-Week low | 2835.00 |
P/E | 36.33 |
Mkt Cap.(Rs cr) | 36,494 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Alkem Laboratories Ltd. (ALKEM) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 1027.65 | 1.95 | 1071.90 | 789.75 | 246564.06 |
Cipla | 1023.00 | -0.19 | 1185.20 | 880.00 | 82571.44 |
Divi's Lab. | 2884.45 | -11.71 | 4640.95 | 2796.10 | 76567.73 |
Dr Reddy's Labs | 4357.90 | -0.28 | 4645.55 | 3655.00 | 72567.75 |
Apollo Hospitals | 4244.75 | 0.28 | 5015.45 | 3365.90 | 61031.01 |
Torrent Pharma. | 1532.20 | -0.55 | 1722.70 | 1242.50 | 51855.78 |
Abbott India | 20867.55 | 1.87 | 22481.80 | 15525.00 | 44343.54 |
Zydus Lifesci. | 434.00 | 0.32 | 458.60 | 319.40 | 43929.48 |
Max Healthcare | 434.90 | -1.25 | 482.50 | 306.00 | 42222.70 |
Alkem Lab | 3052.60 | -0.72 | 3720.00 | 2835.00 | 36493.83 |
Lupin | 739.50 | -0.32 | 916.00 | 583.05 | 33639.86 |
Biocon | 233.40 | -2.40 | 410.50 | 229.70 | 28022.00 |
Aurobindo Pharma | 403.90 | -1.46 | 730.00 | 397.30 | 23664.50 |
Syngene Intl. | 567.35 | 0.88 | 682.25 | 508.10 | 22775.13 |
Ipca Labs. | 855.50 | -0.12 | 1089.00 | 830.00 | 21704.04 |
Glaxosmi. Pharma | 1245.00 | 0.77 | 1734.90 | 1230.70 | 21091.55 |
Fortis Health. | 277.25 | -0.38 | 324.80 | 219.80 | 20931.27 |
Gland Pharma | 1213.30 | -4.91 | 3599.00 | 1200.00 | 19983.05 |
Laurus Labs | 331.20 | -2.24 | 626.00 | 324.25 | 17840.09 |
Pfizer | 3872.35 | 0.50 | 4700.00 | 3768.00 | 17716.00 |
Quick Links for Alkem Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices